This review synthesizes recent advances in the cellular and molecular profiling of chronically stimulated CD8<sup>+</sup> T cells across chronic viral infection and cancer, focusing on regulatory networks, defining factors, and tissue-specific cues that govern functional adaptation and exploring emerging therapeutic reprogramming strategies. This evidence concerns the gene CD8A and cancer.